Literature DB >> 27088785

Two Distinctive Binding Modes of Endonuclease Inhibitors to the N-Terminal Region of Influenza Virus Polymerase Acidic Subunit.

Satoshi Fudo1, Norio Yamamoto2,3, Michiyoshi Nukaga4, Takato Odagiri3, Masato Tashiro3, Tyuji Hoshino1.   

Abstract

Influenza viruses are global threat to humans, and the development of new antiviral agents are still demanded to prepare for pandemics and to overcome the emerging resistance to the current drugs. Influenza polymerase acidic protein N-terminal domain (PAN) has endonuclease activity and is one of the appropriate targets for novel antiviral agents. First, we performed X-ray cocrystal analysis on the complex structures of PAN with two endonuclease inhibitors. The protein crystallization and the inhibitor soaking were done at pH 5.8. The binding modes of the two inhibitors were different from a common binding mode previously reported for the other influenza virus endonuclease inhibitors. We additionally clarified the complex structures of PAN with the same two endonuclease inhibitors at pH 7.0. In one of the crystal structures, an additional inhibitor molecule, which chelated to the two metal ions in the active site, was observed. On the basis of the crystal structures at pH 7.0, we carried out 100 ns molecular dynamics (MD) simulations for both of the complexes. The analysis of simulation results suggested that the binding mode of each inhibitor to PAN was stable in spite of the partial deviation of the simulation structure from the crystal one. Furthermore, crystal structure analysis and MD simulation were performed for PAN in complex with an inhibitor, which was already reported to have a high compound potency for comparison. The findings on the presence of multiple binding sites at around the PAN substrate-binding pocket will provide a hint for enhancing the binding affinity of inhibitors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27088785     DOI: 10.1021/acs.biochem.5b01087

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Aryl and Arylalkyl Substituted 3-Hydroxypyridin-2(1H)-ones: Synthesis and Evaluation as Inhibitors of Influenza A Endonuclease.

Authors:  Hye Yeon Sagong; Joseph D Bauman; Aitor Nogales; Luis Martínez-Sobrido; Eddy Arnold; Edmond J LaVoie
Journal:  ChemMedChem       Date:  2019-05-14       Impact factor: 3.466

2.  Structural and Biochemical Basis for Development of Diketo Acid Inhibitors Targeting the Cap-Snatching Endonuclease of the Ebinur Lake Virus (Order: Bunyavirales).

Authors:  Wenhua Kuang; Huanyu Zhang; Yan Cai; Guilin Zhang; Fei Deng; Hailong Li; Yiwu Zhou; Manli Wang; Peng Gong; Yu Guo; Zhihong Hu
Journal:  J Virol       Date:  2022-03-10       Impact factor: 6.549

3.  Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Burkholderia multivorans.

Authors:  Michiyoshi Nukaga; Michael J Yoon; Magdalena A Taracilia; Tyuji Hoshino; Scott A Becka; Elise T Zeiser; Joseph R Johnson; Krisztina M Papp-Wallace
Journal:  ACS Infect Dis       Date:  2021-03-16       Impact factor: 5.084

Review 4.  The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.

Authors:  Annelies Stevaert; Lieve Naesens
Journal:  Med Res Rev       Date:  2016-08-29       Impact factor: 12.944

Review 5.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

6.  The First 5'-Phosphorylated 1,2,3-Triazolyl Nucleoside Analogues with Uracil and Quinazoline-2,4-Dione Moieties: A Synthesis and Antiviral Evaluation.

Authors:  Dmitry A Tatarinov; Bulat F Garifullin; Mayya G Belenok; Olga V Andreeva; Irina Yu Strobykina; Anna V Shepelina; Vladimir V Zarubaev; Alexander V Slita; Alexandrina S Volobueva; Liliya F Saifina; Marina M Shulaeva; Vyacheslav E Semenov; Vladimir E Kataev
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

7.  Synthesis and Antiviral Evaluation of Nucleoside Analogues Bearing One Pyrimidine Moiety and Two D-Ribofuranosyl Residues.

Authors:  Olga V Andreeva; Bulat F Garifullin; Vladimir V Zarubaev; Alexander V Slita; Iana L Yesaulkova; Alexandrina S Volobueva; Mayya G Belenok; Maria A Man'kova; Liliya F Saifina; Marina M Shulaeva; Alexandra D Voloshina; Anna P Lyubina; Vyacheslav E Semenov; Vladimir E Kataev
Journal:  Molecules       Date:  2021-06-16       Impact factor: 4.411

8.  Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease.

Authors:  Diane Beylkin; Gyanendra Kumar; Wei Zhou; Jaehyeon Park; Trushar Jeevan; Chandraiah Lagisetti; Rhodri Harfoot; Richard J Webby; Stephen W White; Thomas R Webb
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

9.  New anti-viral drugs for the treatment of COVID-19 instead of favipiravir.

Authors:  Ahmet Aktaş; Burak Tüzün; Rukiye Aslan; Koray Sayin; Hilmi Ataseven
Journal:  J Biomol Struct Dyn       Date:  2020-08-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.